Lilly Sues Barr on Prozac Patent

The branded drugmaker faces off with a generic rival.
Author:
Publish date:

Pharmaceutical products maker

Barr Pharmaceuticals

(BRL)

said

Eli Lilly

(LLY) - Get Report

sued Barr Laboratories, claiming Barr's generic form of antidepressant Prozac infringes the patent on Lilly's branded medicine.

The Woodcliff Lake, N.J.-based company said it is the first generic drugmaker to file an abbreviated new drug application with the FDA for the 90 mg capsule product.

This story was created through a joint venture between TheStreet.com and IRIS.